Affronti, M. L., Friedman, H. S., Desjardins, A., Vlahovic, G., Randazzo, D. M., Herndon, J. E., . . . Peters, K. B. (2015). ATCT-01 PHASE II STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RILOTUMUMAB AND BEVACIZUMAB (BEV) IN SUBJECTS WITH RECURRENT MALIGNANT GLIOMA (MG). Neuro Oncol.

Affronti, Mary L., et al. "ATCT-01 PHASE II STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RILOTUMUMAB AND BEVACIZUMAB (BEV) IN SUBJECTS WITH RECURRENT MALIGNANT GLIOMA (MG)." Neuro Oncol 2015.

Affronti, Mary L., et al. "ATCT-01 PHASE II STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RILOTUMUMAB AND BEVACIZUMAB (BEV) IN SUBJECTS WITH RECURRENT MALIGNANT GLIOMA (MG)." Neuro Oncol 2015.